Start broad or start narrow? Both routes are wrong!
Faced with a suspected infection, a doctor has two classic options. Start with a broad-spectrum antibiotic and narrow it later, which fuels resistance. Or start narrow and escalate if it fails, which puts the patient at risk. So what is the right approach? Dr Luke Moore and Prof. Maria Virginia Villegas answer in this insightful episode.
In this episode
- The prescribing dilemma: why both classic antibiotic strategies carry a cost, and what to do about it.
- Beyond the patient: how one test can also support surveillance, infection control, surgery, and the preservation of antibiotics.
- The economic case: why the price of a single test is the wrong measure.
- The role of antimicrobial stewardship teams.
- Better evidence, better education: which outcomes studies should measure, and how to bring diagnostics into everyday clinical practice.
“Broad is just killing a lot of bacteria that are not involved in the infection… so the next infection of the patient will be with a multidrug-resistant bacteria”
“Either I’m ruining antibiotic resistance by starting broad then narrowing, or I’m putting my patient at risk by starting narrow, failing, and then having to broaden.”
Meet the Experts
Listen Anywhere
Critical conversations: Voices of AMR experts is available on most podcast platforms.
The scientific content in the above materials has been developed independently by the speaker(s)/author(s). The views presented in these materials are the authors’ personal opinions and do not necessarily represent the viewpoint, strategy or opinions of bioMérieux.
The content on this website and associated materials may discuss scientific research, emerging evidence, or clinical practices that may not be approved, cleared, or available in all countries. Such information is provided solely for educational and scientific exchange and users are responsible for consulting and complying with applicable local law and regulatory requirements. The content on this website and associated materials do not constitute medical advice and should not be considered a substitute for the individual professional judgement of any physician or other health care practitioner regarding the appropriate course of action for a particular patient. All recommendations should be independently reviewed with appropriate medical staff in light of the needs of any particular institution and its patients. bioMérieux makes no guarantee or representation regarding the accuracy, completeness, or usefulness of this information for any particular purpose, including but not limited to any cost savings.